Less is more: role of additional chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal cancer management
Yong Chan Ahn
Radiat Oncol J. 2019;37(2):67-72.   Published online 2019 Jun 30     DOI: https://doi.org/10.3857/roj.2019.00311
Citations to this article as recorded by Crossref logo
Impact of induction chemotherapy with concurrent chemoradiotherapy on nasopharyngeal carcinoma: A meta-analysis of randomized controlled trials
Ting-Chieh Huang, Chi-Jen Chen, Yi-Fang Ding, Yi-No Kang
Frontiers in Oncology.2022;[Epub]     CrossRef
Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
Chin King Looi, Ling-Wei Hii, Felicia Fei-Lei Chung, Chun-Wai Mai, Wei-Meng Lim, Chee-Onn Leong
Cancers.2021; 13(8): 1786.     CrossRef
An Updated Review on Head and Neck Cancer Treatment with Radiation Therapy
Garrett Anderson, Maryam Ebadi, Kim Vo, Jennifer Novak, Ameish Govindarajan, Arya Amini
Cancers.2021; 13(19): 4912.     CrossRef
Applying the ASCO and European Society for Medical Oncology Value Frameworks to Nasopharyngeal Cancer Treatments: Is Adding Induction Chemotherapy or Adjuvant Chemotherapy to Concurrent Chemoradiotherapy Worthwhile?
Teng Hwee Tan, Yu Yang Soon, Timothy Cheo, Lea Choung Wong, Yiat Horng Leong, Jeremy C.S. Tey, Francis Ho
JCO Oncology Practice.2020; 16(11): e1386.     CrossRef
Dosimetric Comparison of Noncoplanar and Coplanar Volumetric Modulated Arc Therapy Plans for Esophageal Cancer
So-Yeon Park
Progress in Medical Physics.2020; 31(4): 179.     CrossRef